Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2008-10-24
2010-12-14
Chernyshev, Olga N (Department: 1649)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S013500, C514S001100
Reexamination Certificate
active
07851446
ABSTRACT:
The present invention relates to the use of therapeutic human albumin for the preparation of a drug for the treatment of patients suffering from cognitive disorders. In particular, the invention relates to methods of treating patients suffering from cognitive disorders, in which the mode of administration of the drug comprises the administration to the patient for a minimum of three successive times of a therapeutically effective amount of human therapeutic albumin by plasma exchange and/or intravenous perfusion, independently of the content of Aβ in the patient's blood.
REFERENCES:
patent: 4900720 (1990-02-01), Kotitschke et al.
patent: 5112298 (1992-05-01), Prince et al.
patent: 5178603 (1993-01-01), Prince
patent: 2005/0239062 (2005-10-01), Zlokovic
patent: 1576955 (2005-09-01), None
patent: WO-03/051374 (2003-06-01), None
patent: WO-2004031161 (2004-04-01), None
patent: WO-2004/071524 (2004-08-01), None
patent: WO-2005065069 (2005-07-01), None
patent: WO-2006/005706 (2006-01-01), None
patent: WO-2007/0010435 (2007-01-01), None
Purves, et al, in:Neuroscience. Sunderland (MA). Sinauer Associates, Inc.; c2001.<<http://www.ncbi.nlm.nih.gov/books/bv.fcgi?highlight=hippocampus,emotion&rid=neurosci.section.2041>>Accessed Jan. 14, 2009.
Rossler, et al, 2002. “Stage-dependent and sector-specific neuronal loss in hippocampus during Alzheimer's disease”. Acta Neuropathol (2002) 103:363-369.
McKhann, et al, 1984. “Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease”, Neurology 34:939-944.
Folstein, et al, 1975 “Mini-Mental State”. J Psychiat Res 12:189-198.
Rosen, et al., 1984. “A New Rating Scale for Alzheimer's Disease”, Am J Psychiatry 141: 1356-1364.
Buchanan & Ingersoll & Rooney PC
Chernyshev Olga N
Grifols, S.A.
LandOfFree
Use of therapeutic human albumin for treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of therapeutic human albumin for treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of therapeutic human albumin for treatment of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4166729